Funder
Jazz Pharmaceuticals, Inc
Celgene Corporation
Jazz Pharmaceuticals plc
Takeda Pharmaceuticals U.S.A., Inc
Subject
Transplantation,Hematology
Reference81 articles.
1. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome;Coppell;Biol Blood Marrow Transplant,2010
2. Fatal veno-occlusive disease of the liver after chemotherapy, whole body irradiation and bone marrow transplantation for refractory acute leukemia;Jacobs;S Afr Med J,1979
3. Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients;Barker;Bone Marrow Transplant,2003
4. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors;McDonald;Hepatology,1984
5. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies;Ho;Bone Marrow Transplant,2008
Cited by
228 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献